Eman M Mantawy
Overview
Explore the profile of Eman M Mantawy including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
269
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mostafa F, Mantawy E, Said R, Azab S, El-Demerdash E
Psychopharmacology (Berl)
. 2025 Jan;
242(3):563-578.
PMID: 39809925
Rationale: One of the most debilitating drawbacks of cisplatin chemotherapy is neurotoxicity which elicits memory impairment and cognitive dysfunction (chemobrain). This is primarily triggered by oxidative stress and inflammation. Captopril,...
2.
Mohamed D, Said R, Kassem D, Gad A, El-Demerdash E, Mantawy E
Toxicol Appl Pharmacol
. 2024 Sep;
492:117111.
PMID: 39326792
Young women suffering from premature ovarian failure after radiotherapy carry a huge burden in the field of cancer therapy including reproductive loss, emotional stress, and physical troubles that reduce their...
3.
Gamal El-Din M, Mantawy E, Said R, Fahmy N, Fayez S, Shahin M, et al.
Arch Pharm (Weinheim)
. 2024 Sep;
357(11):e2400392.
PMID: 39240066
Hibiscus species (Malvaceae) possess a plethora of appealing pharmacological activities with an extended history of customary use in diverse medical conditions. The present study aimed at comparing the metabolomic analyses...
4.
Hussein Z, Michel H, El-Naga R, El-Demerdash E, Mantawy E
Neurotoxicology
. 2024 Aug;
105:21-33.
PMID: 39209270
Deterioration in the neurocognitive function of cancer patients referred to as "Chemobrain" is a devastating obstacle associated with cyclophosphamide (CYP). CYP is an alkylating agent, clinically utilized as an efficient...
5.
Abdelhamid A, Mantawy E, Said R, El-Demerdash E
Toxicol Appl Pharmacol
. 2024 Jun;
489:116994.
PMID: 38857790
Radiation-induced cognitive impairment has recently fueled scientific interest with an increasing prevalence of cancer patients requiring whole brain irradiation (WBI) in their treatment algorithm. Saxagliptin (SAXA), a dipeptidyl peptidase-IV (DPP-IV)...
6.
Ibrahim K, Darwish S, Mantawy E, El-Demerdash E
Mol Cell Biochem
. 2023 Jul;
479(8):1873-1893.
PMID: 37522975
Cyclophosphamide has drastically enhanced the expectancy and quality of life of cancer patients. However, it is accompanied by diverse neurological complications which are considered a dose-limiting adverse effect. Neurotoxicity caused...
7.
Abdel-Aziz A, Mantawy E, Said R, Helwa R
Exp Neurol
. 2023 Jan;
362:114328.
PMID: 36707333
No abstract available.
8.
Mahmoud A, Mantawy E, Wahdan S, Ammar R, El-Demerdash E
Biomed Pharmacother
. 2023 Jan;
159:114238.
PMID: 36640673
Cisplatin (CP) is a broad-spectrum antineoplastic agent used to treat many human cancers. Nonetheless, most patients receiving CP suffer from cognitive deficits, a phenomenon termed "chemo-brain". Recently, vildagliptin (Vilda), a...
9.
Hendawy A, El-Lakkany N, Mantawy E, Hammam O, Botros S, El-Demerdash E
Life Sci
. 2022 Jun;
304:120695.
PMID: 35671811
Aims: This study investigates the therapeutic potential of Vilda in a NASH model with liver fibrosis and elucidates the underlying molecular mechanisms. Main Methods: To induce NASH, male Sprague-Dawley rats...
10.
Sakr M, Elkhatib W, Aboshanab K, Mantawy E, Yassien M, Hassouna N
AMB Express
. 2021 Jul;
11(1):109.
PMID: 34313869
Failure in the treatment of P. aeruginosa, due to its broad spectrum of resistance, has been associated with increased patient mortality. One alternative approach for infection control is quorum quenching...